These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 5011421)

  • 1. Interaction of the effects of naloxone and oxymorphone on human respiration.
    Kallos T; Hudson HE; Rouge JC; Smith TC
    Anesthesiology; 1972 Mar; 36(3):278-85. PubMed ID: 5011421
    [No Abstract]   [Full Text] [Related]  

  • 2. Naloxone, naltrexone, and related noroxymorphones.
    Blumberg H; Dayton HB
    Adv Biochem Psychopharmacol; 1973; 8(0):33-43. PubMed ID: 4794989
    [No Abstract]   [Full Text] [Related]  

  • 3. Assays for narcotic antagonist activity in rodents.
    Pierson AK
    Adv Biochem Psychopharmacol; 1973; 8(0):245-61. PubMed ID: 4152786
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of late fentanyl-induced respiratory depression after the injection of opiate antagonists naltrexone and S-20682: comparison with naloxone.
    Freye E; Hartung E; Kaliebe S
    Br J Anaesth; 1983 Jan; 55(1):71-7. PubMed ID: 6129881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Counteraction of narcotic antagonist analgesics by the narcotic antagonist Naloxone.
    Blumberg H; Dayton HB; Wolf PS
    Proc Soc Exp Biol Med; 1966 Dec; 123(3):755-8. PubMed ID: 4381176
    [No Abstract]   [Full Text] [Related]  

  • 6. Homobenzomorphan compounds with a potent narcotic antagonist property.
    Nurimoto S; Suzuki S; Hayashi G; Takeda M
    Jpn J Pharmacol; 1974 Jun; 24(3):461-9. PubMed ID: 4449151
    [No Abstract]   [Full Text] [Related]  

  • 7. Levallorphan and meperidine mixtures. A dose-response study of the ventilatory sensitivity to carbon dioxide.
    Rouge JC
    Acta Anaesthesiol Scand; 1969; 13(2):87-96. PubMed ID: 5367473
    [No Abstract]   [Full Text] [Related]  

  • 8. The respiratory, circulatory, and analgesic effects of naloxone-narcotic mixtures in anaesthetized subjects.
    Foldes FF; Davidson GM; Duncalf D; Kuwabara S; Siker ES
    Can Anaesth Soc J; 1965 Nov; 12(6):608-21. PubMed ID: 5865529
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparative study of the narcotic against activity of naloxone and levallorphan.
    Evans JM; Hogg MI; Lunn JN; Rosen M
    Anaesthesia; 1974 Nov; 29(6):721-7. PubMed ID: 4429197
    [No Abstract]   [Full Text] [Related]  

  • 10. Opiate agonists and antagonists discriminated by receptor binding in brain.
    Pert CB; Pasternak G; Snyder SH
    Science; 1973 Dec; 182(4119):1359-61. PubMed ID: 4128222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levallorphan and related compounds.
    Leimgruber W; Mohacsi E; Baruth H; Randall LO
    Adv Biochem Psychopharmacol; 1973; 8(0):45-50. PubMed ID: 4794970
    [No Abstract]   [Full Text] [Related]  

  • 12. The peripheral narcotic antagonist N-allyl levallorphan-bromide (CM 32191) selectively prevents morphine antipropulsive action and buprenorphine in-vivo binding in the rat intestine.
    Bianchi G; Fiocchi R; Peracchia F; Petrillo P; Tavani A; Manara L
    J Pharm Pharmacol; 1984 May; 36(5):326-30. PubMed ID: 6145770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naloxone reversal of oxymorphone effects in dogs.
    Copland VS; Haskins SC; Patz J
    Am J Vet Res; 1989 Nov; 50(11):1854-8. PubMed ID: 2482683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CLINICAL OBSERVATIONS ON THE PREANESTHETIC USE OF OXYMORPHONE AND ITS ANTAGONIST, N-ALLYL-NOROXYMORPHONE, IN DOGS.
    NYTCH TF
    J Am Vet Med Assoc; 1964 Jul; 145():127-31. PubMed ID: 14196276
    [No Abstract]   [Full Text] [Related]  

  • 15. Antagonists in the homobenzomorphan series.
    Takeda M; Konda M; Inoue H; Saito S; Kugita H
    Adv Biochem Psychopharmacol; 1973; 8(0):113-21. PubMed ID: 4794865
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of a new analgesic, MR 1268, on circulatory and respiratory indices in volunteers.
    Samuel IO; Clarke RS; Dundee JW; Wilson JJ
    Br J Anaesth; 1981 Dec; 53(12):1329-35. PubMed ID: 6797454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The increased efficacy of narcotic antagonists induced by various narcotic analgesics.
    Tulunay FC; Takemori AE
    J Pharmacol Exp Ther; 1974 Sep; 190(3):395-400. PubMed ID: 4416308
    [No Abstract]   [Full Text] [Related]  

  • 18. Respiratory depression from alkalosis and opioid interaction in man.
    Hudson HE; Harber PI; Smith TC
    Anesthesiology; 1974 Jun; 40(6):543-52. PubMed ID: 4597942
    [No Abstract]   [Full Text] [Related]  

  • 19. The respiratory, circulatory, and narcotic antagonistic effects of nalorphine, levallorphan, and naloxone in anaesthetized subjects.
    Foldes FF; Duncalf D; Kuwabara S
    Can Anaesth Soc J; 1969 Mar; 16(2):151-61. PubMed ID: 5773493
    [No Abstract]   [Full Text] [Related]  

  • 20. Respiratory effects of butorphanol and pethidine.
    Kallos T; Caruso FS
    Anaesthesia; 1979; 34(7):633-7. PubMed ID: 517715
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.